Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Feb 21, 2026
Arm Holdings (ARM) Stock Analysis: AI Expansion Redefines the Growth Narrative

Arm Holdings (ARM) Stock Analysis: AI Expansion Redefines the Growth Narrative

Key Takeaways

  • Arm reported fiscal Q3 2026 revenue of $1.24 billion, up 26% year-over-year, exceeding expectations.

  • Royalty revenue climbed 27% to $737 million, driven primarily by accelerating data center and AI adoption.

  • Licensing revenue rose 25% year-over-year but fell short of forecasts due to deal timing.

  • Analysts offered mixed reactions, though overall sentiment remains constructive with AI strength offsetting smartphone concerns.

  • Shares recovered after an initial post-earnings selloff as investors refocused on Arm’s expanding AI footprint.

Market Snapshot: Volatility Followed by Stabilization

Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.

Broader rotation back into technology stocks has further supported the shares. Investors increasingly view Arm not merely as a mobile architecture leader, but as a foundational player in hyperscaler custom silicon and cloud infrastructure. Trading activity reflects growing conviction in Arm’s strategic evolution beyond smartphones and into the expanding AI ecosystem.

Earnings Breakdown: AI Momentum Offsets Mobile Weakness

On February 4, 2026, Arm reported fiscal Q3 revenue of $1.242 billion, representing 26% year-over-year growth and surpassing consensus expectations.

Royalty revenue reached $737 million, up 27% from the prior year. Growth was fueled by:

  • Accelerating adoption of Armv9 architecture

  • More than doubling of data center royalties

  • Expanding hyperscaler deployment

Licensing and other revenue rose 25% to $505 million but missed estimates due to timing variability in large deals. Adjusted EPS came in at $0.43, beating forecasts by approximately 30%, highlighting operational leverage despite macro and supply-chain challenges.

Post-Earnings Volatility

Shares initially fell about 8% in after-hours trading following the report. The selloff stemmed from:

  • Licensing revenue coming in below expectations

  • Management commentary on smartphone weakness linked to memory shortages

  • Indications that supply constraints could reduce fiscal 2027 royalties by 1–2%

Qualcomm’s concurrent caution on mobile supply issues compounded sector concerns.

However, sentiment reversed quickly. The stock rebounded more than 5% the following session as investors focused on stronger forward guidance and continued AI momentum.

Guidance Signals Continued Expansion

For fiscal Q4, management guided to:

  • Revenue of approximately $1.47 billion (± $50 million)

  • Low-teens royalty growth

  • High-teens licensing growth

Arm emphasized sustained AI demand across cloud, automotive, and infrastructure segments. The company noted that hyperscaler CPU share is nearing 50%, reflecting expanding penetration in cloud environments.

Management underscored “strong momentum for AI across every layer of computing,” highlighting continued Compute Subsystem adoption in both smartphones and data centers.

Analyst Reaction: Mixed but Constructive

Wall Street’s response was varied but leaned positive overall.

  • New Street Research upgraded the stock to Buy, arguing smartphone concerns were overstated given premium device resilience and data center offsets.

  • Morgan Stanley reiterated Buy with a $135 price target, citing durable royalty growth.

  • Bank of America raised its price target to $135 from $115 while maintaining Neutral.

Meanwhile:

  • JPMorgan lowered its target to $145 from $180.

  • Mizuho cut its target to $160 from $190.

Downgrades centered on valuation concerns and memory-related risks. Still, consensus price targets cluster in the $150–$160 range, implying meaningful upside from current levels.

Investor sentiment also benefited from SoftBank’s improved outlook and Arm’s increasing strategic importance within AI infrastructure. The upcoming “Arm Everywhere” event in March could provide additional visibility into product roadmaps and silicon strategy.

2026 Outlook: Structural Shift Toward AI and Data Centers

Looking ahead, Arm’s growth trajectory increasingly depends on its transition from mobile-centric revenues toward AI and cloud infrastructure.

Key themes to monitor include:

1. Data Center Expansion

Management expects data centers to become Arm’s largest segment. With CPU share among top cloud providers nearing 50%, inference workloads are expanding the role of CPUs alongside GPUs in AI systems.

Armv9 adoption and custom ASIC development for hyperscalers are expected to drive approximately 20% top-line growth in fiscal 2027.

2. Diversification Beyond Mobile

While smartphone volumes face cyclical and supply-driven pressure, premium-tier resilience and architectural upgrades remain supportive. Automotive, IoT, and Compute Subsystems represent additional growth vectors within an industry projected to expand at roughly 8% CAGR.

3. Margin and Cost Considerations

Elevated R&D investments could weigh on margins in the near term, though strong free cash flow provides flexibility. Royalty mix shifts and backlog conversion will be critical indicators of sustained earnings power.

4. Risks and Regulatory Factors

  • Memory shortages and prolonged smartphone replacement cycles

  • Competitive pressures in chip architecture

  • Regulatory scrutiny around AI energy usage

Bottom Line

Arm’s latest results reinforce a broader strategic pivot: from a mobile-dominated licensing model toward a diversified AI and data center royalty engine. While near-term smartphone risks and valuation concerns introduce volatility, structural growth drivers tied to AI infrastructure appear increasingly durable.

The market’s quick recovery after earnings suggests investors are prioritizing long-term AI exposure over short-term mobile softness. As Arm deepens its role in hyperscaler silicon and AI compute layers, its growth narrative continues to evolve beyond its mobile roots.

Tickeron AI Perspective

Disclaimers and Limitations


Contributor

Dem Sem's AvatarDem Sem|Expert

Interact to see
Advertisement
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Cincinnati Financial (CINF) reports Q4 2025 earnings on February 9, 2026, after market close, with consensus EPS of $2.86–$2.89 and revenue around $2.91 billion. Allstate (ALL) recently reported Q4 2025 EPS of $14.31, well above the $8.72 estimate, with revenue of $17.3 billion on February 4, 2026.
Coca-Cola (KO) reports Q4 2025 earnings on February 10, 2026, with consensus EPS of $0.56 and revenue of $12.05 billion. PepsiCo (PEP) beat Q4 2025 estimates on February 3, reporting adjusted EPS of $2.26 (vs. $2.24 expected) and revenue of $29.34 billion.
(AZN) AstraZeneca’s full-year 2025 results, set for February 10, 2026, cap a year of sustained growth amid competitive pressures. Following 21% total revenue growth in FY 2024 and 19% core EPS expansion, AZN has maintained momentum with 11% revenue growth through nine months of 2025. The report offers insight into:
Gilead Sciences (GILD): Q4 2025 earnings due February 10, consensus EPS $1.83, revenue $7.68B. Growth driven by HIV franchise; oncology investments like Trodelvy may offer upside. Amgen (AMGN): Reported Q4 2025 EPS $5.29 vs $4.73 expected, revenue $9.9B (+9% YoY). Strong 2026 guidance: $37–38.4B revenue, $21.60–23.00 non-GAAP EPS.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Arm Holdings (ARM) Stock Analysis: AI Expansion Redefines the Growth Narrative